BioSpace News Archive

Clovis Oncology, Inc. (NASDAQ:CLVS) reported financial results for the quarter ended March 31, 2022, and provided an update on the Company’s clinical development programs and regulatory and commercial outlook.

Bristol Myers Squibb (NYSE: BMY) today announced that the company will take part in a fireside chat at the Bank of America Securities 2022 Healthcare Conference in Las Vegas, Nevada on Wednesday, May 11, 2022.

Humanigen, Inc. announced today that management will present and participate at multiple investors conferences in May 2022.

Orthofix Medical Inc today announced the U.S. Food and Drug Administration (FDA) pre-market approval for the AccelStim ™ bone healing therapy Class III device.

ADC Therapeutics SA announced today that its executives will be participating in a fireside chat at the BofA Securities 2022 Healthcare Conference on Tuesday, May 10, 2022, at 1:40 pm ET.

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel LAG-3-related immunotherapy treatments for cancer and autoimmune disease, today reports new biomarker and exploratory analysis data from its Phase IIb AIPAC trial.

CathVision, a medical technology company developing innovative electrophysiology solutions designed to enhance clinical decision making in the EP lab, today announced the FDA 510(k) clearance of the ECGenius EP Recording System.

Alnylam Pharmaceuticals, Inc. announced that management will present company overviews at the following conferences.

Juniper Biologics Pte Ltd and Helsinn Group announced the signing of an exclusive license agreement to develop and commercialise infigratinib in Australia, New Zealand, Southeast Asia and certain markets in the Middle East and Africa for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 fusion or other rearrangement.

Chemomab Therapeutics Ltd today announced the company will release its first quarter 2022 financial results and provide a business update on Thursday, May 12, 2022.